About Careers Internship MedBlog Contact us
Medindia LOGIN REGISTER
Advertisement

Experimental Vaccine can Help Reduce Shedding of Herpes Simplex Virus

by Kathy Jones on September 15, 2013 at 7:27 PM
 Experimental Vaccine can Help Reduce Shedding of Herpes Simplex Virus

A new study conducted by IU School of Medicine and to be presented at the Interscience Conference on Antimicrobial Agents and Chemotherapy in Denver reports that an experimental vaccine for herpes simplex virus type 2, called GEN-003, can help reduce viral shedding. The vaccine has been developed by Genocea Biosciences of Cambridge, Mass.

"Typically vaccines do not modulate a disease someone already has contracted," said Fife, a professor of medicine and of microbiology and immunology. "The virus can be detected on the skin of people with genital herpes even when they are not having an outbreak. That is often how the disease is spread, often called viral shedding."

Advertisement

The injectable vaccine is given several times over the course of a few weeks. The clinical study is closed to enrollment, but participants continue to be followed. GEN-003 is one of the first vaccines intended to reduce the viral shedding and frequency and severity of outbreaks and transmission of herpes simplex virus type 2, which is the most common cause of genital herpes. It is estimated to infect more than 500 million people worldwide, and one out of six people age 14 to 49. In the U.S., an estimated 50-60 million people are affected.

"Although the ultimate goal of this vaccine is reducing genital herpes outbreaks and reducing transmission of the virus to others, this is only the first step on a long path toward reaching that goal. It will take several more studies and a number of years to determine if we can reach that goal," Fife cautioned.



Source: Eurekalert
Font : A-A+

Advertisement

Advertisement
Advertisement

Recommended Readings

Latest Research News

Brain Circuits That Shape Bedtime Rituals in Mice
New study sheds light on the intrinsic, yet often overlooked, role of sleep preparation as a hardwired survival strategy.
NELL-1 Protein Aids to Reduce Bone Loss in Astronauts
Microgravity-induced bone loss in space, can be reduced by systemic delivery of NELL-1, a protein required for bone growth and its maintenance.
Connecting Genetic Variants to the Alzheimer's Puzzle
Researchers establish connections between Alzheimer's-linked genetic alterations and the functioning of brain cells.
Gene Therapy Sparks Spinal Cord Regeneration
Team at NeuroRestore introduces a groundbreaking gene therapy that has effectively promoted nerve regrowth and reconnection, post spinal cord injury.
Unlocking the Gut Microbiome's Influence on Bone Density
Scientists aim to pinpoint particular functional pathways affected by these bacteria that may have an impact on skeletal health.
View All
This site uses cookies to deliver our services.By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use  Ok, Got it. Close
MediBotMediBot
Greetings! How can I assist you?MediBot
×

Experimental Vaccine can Help Reduce Shedding of Herpes Simplex Virus Personalised Printable Document (PDF)

Please complete this form and we'll send you a personalised information that is requested

You may use this for your own reference or forward it to your friends.

Please use the information prudently. If you are not a medical doctor please remember to consult your healthcare provider as this information is not a substitute for professional advice.

Name *

Email Address *

Country *

Areas of Interests